Roflumilast cream has long-term safety, efficacy in young children

For children aged 2 to 5 years with atopic dermatitis (AD), roflumilast cream 0.05% has a favorable long-term safety profile and efficacy for up to 56 weeks, according to a study published online March 8 in Pediatric Dermatology…
Read More

About The Author

Jonathan Jeriah

See author's posts